Chaos Based Encryption Technique for Compressed H264/AVC Videos
El-Mowafy, M. A., Gharghory, S. M., Abo-Elsoud, M. A., Obayya, M., Fath Allah, M. I.
Published in IEEE access (2022)
Published in IEEE access (2022)
Get full text
Journal Article
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck – the RESGEX study
Klinghammer, K., Fayette, J., Kawecki, A., Dietz, A., Schafhausen, P., Folprecht, G., Rottey, S., Debourdeau, P., Lavernia, J., Jacobs, A., Ahrens-Fath, I., Dietrich, B., Baumeister, H., Zurlo, A., Ochsenreither, S., Keilholz, U.
Published in ESMO open (01.10.2021)
Published in ESMO open (01.10.2021)
Get full text
Journal Article
Maintenance therapy of patients with recurrent epithelial ovarian carcinoma with the anti-tumor-associated-mucin-1 antibody gatipotuzumab: results from a double-blind, placebo-controlled, randomized, phase II study
Ledermann, J.A., Zurawski, B., Raspagliesi, F., De Giorgi, U., Arranz Arija, J., Romeo Marin, M., Lisyanskaya, A., Póka, R.L., Markowska, J., Cebotaru, C., Casado Herraez, A., Colombo, N., Kutarska, E., Hall, M., Jacobs, A., Ahrens-Fath, I., Baumeister, H., Zurlo, A., Sehouli, J.
Published in ESMO open (01.02.2022)
Published in ESMO open (01.02.2022)
Get full text
Journal Article
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors
Ochsenreither, S., Fiedler, W.M., Conte, G.D., Macchini, M., Matos, I., Habel, B., Ahrens-Fath, I., Raspagliesi, F., Lorusso, D., Keilholz, U., Rolling, C., Kebenko, M., Klinghammer, K.F., Saavedra, O., Baumeister, H., Zurlo, A., Garralda, E.
Published in ESMO open (01.04.2022)
Published in ESMO open (01.04.2022)
Get full text
Journal Article
Erratum to ‘Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors’: [ESMO Open Volume 7, Issue 2, April 2022, 100447]
Ochsenreither, S., Fiedler, W.M., Del Conte, G., Macchini, M., Matos, I., Habel, B., Ahrens-Fath, I., Raspagliesi, F., Lorusso, D., Keilholz, U., Rolling, C., Kebenko, M., Klinghammer, K.F., Saavedra, O., Baumeister, H., Zurlo, A., Garralda, A.
Published in ESMO open (01.08.2022)
Published in ESMO open (01.08.2022)
Get full text
Journal Article
Comparison of Stresses Generated within the Supporting Structures of Mandibular Second Molars Restored with Different Crown Materials: 3-D Finite Element Analysis (FEA)
Abuelenain, Dalia A., Ajaj, Reem, El-Bab, Eman I. M. Fath, Hammouda, Mohammad M. I.
Published in Journal of prosthodontics (01.08.2015)
Published in Journal of prosthodontics (01.08.2015)
Get full text
Journal Article
Results from the primary analysis of a 30 patient extension of the GATTO study, a phase Ib study combining the anti-MUC1 Gatipotuzumab (GAT) with the anti-EGFR Tomuzotuximab (TO) or Panitumumab in patients with refractory solid tumors
Macchini, M., Garralda, E., Fiedler, W., Del Conte, G., Rolling, C., Kebenko, M., Klinghammer, K.F., Ahrens-fath, I., Habel, B., Baumeister, H., Zurlo, A., Ochsenreiter, S.
Published in European journal of cancer (1990) (01.10.2020)
Published in European journal of cancer (1990) (01.10.2020)
Get full text
Journal Article
Saccharomyces cerevisiae CDC25 (1028-1589) is a guanine nucleotide releasing factor for mammalian ras proteins and is oncogenic in NIH3T3 cells
Chevallier-Multon, M.C., Schweighoffer, F., Barlat, I., Baudouy, N., Fath, I., Duchesne, M., Tocqué, B.
Published in The Journal of biological chemistry (25.05.1993)
Published in The Journal of biological chemistry (25.05.1993)
Get full text
Journal Article
Erratum to ‘Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors’: ESMO Open Volume 7, Issue 2, April 2022, 100447
Ochsenreither, S., Fiedler, W.M., Del Conte, G., Macchini, M., Matos, I., Habel, B., Ahrens-Fath, I., Raspagliesi, F., Lorusso, D., Keilholz, U., Rolling, C., Kebenko, M., Klinghammer, K.F., Saavedra, O., Baumeister, H., Zurlo, A., Garralda, A.
Published in ESMO open (13.07.2022)
Published in ESMO open (13.07.2022)
Get full text
Journal Article
The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event?
Douard, Véronique, Brunet, Frédéric, Boussau, Bastien, Ahrens-Fath, Isabelle, Vlaeminck-Guillem, Virginie, Haendler, Bernard, Laudet, Vincent, Guiguen, Yann
Published in BMC evolutionary biology (18.12.2008)
Published in BMC evolutionary biology (18.12.2008)
Get full text
Journal Article
The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells
Barlat, I, Schweighoffer, F, Chevallier-Multon, M C, Duchesne, M, Fath, I, Landais, D, Jacquet, M, Tocque, B
Published in Oncogene (01.01.1993)
Get more information
Published in Oncogene (01.01.1993)
Journal Article
Study Of Performance Parameters Effects On OFDM Systems
Mohamed, M A, Samarah, A S, Allah, M I Fath
Published in International journal of computer science issues (01.05.2012)
Get full text
Published in International journal of computer science issues (01.05.2012)
Journal Article
Implementation of Adaptive OFDM System Using FPGA
Mohamed, M A, Samarah, A S, Allah, M I Fath
Published in International journal of computer science issues (01.05.2012)
Get full text
Published in International journal of computer science issues (01.05.2012)
Journal Article
Implementation of the OFDM Physical Layer Using FPGA
Mohamed, M A, Samarah, A S, Allah, M I Fath
Published in International journal of computer science issues (01.03.2012)
Get full text
Published in International journal of computer science issues (01.03.2012)
Journal Article